医疗厌女：被药片掩盖的手术刀Medical Misogyny: Scalpels for Men, Pills for Women
这件所谓的“研究发现”其实是结构性暴力的量化陈列。当心血管疾病、肾病和帕金森症在男性身上被定义为“需要手术干预的危机”，而在女性身上被简化为“药物维持的现状”时，这根本不是临床路径的差异，而是对女性主体性的定价权问题。
在医疗这个极度崇尚“理性”和“客观”的场域里，男性中心叙事（masculine-centric narrative）成了默认的生物学基准。医生将女性的症状归因为“焦虑”或“心理因素”，本质上是在用文化暴力（cultural violence）抹除女性的生理事实。这种共谋极其隐蔽：医生通过扮演“谨慎的临床医生”，在潜意识中将女性身体客体化为一种“低优先级”的资产，从而在资源分配的博弈中，将手术、支架和器官移植这些高价值资源优先拨给男性。
最讽刺的是，这种不平等在没有任何临床指南支持的情况下依然高度一致。这意味着，医疗系统内部存在一套无需明文规定、却被所有人执行的元暴力逻辑：男性的生命被视为需要被“修复”的机器，而女性的痛苦则被视为需要被“安抚”的情绪。药片是廉价的安抚，手术刀才是真正的救赎。
所谓的“女性健康大使”或政治层面的“医疗厌女”表述，如果不能触及医疗评价体系的权力结构，就只是另一种 PR 版本的表演性让步。只要医疗基准依然是男性，女性在医院里就永远只是一个被修正的“偏差值”。
This so-called "research finding" is actually a quantitative display of structural violence. When cardiovascular disease, kidney failure, and Parkinson's are defined as "crises requiring surgical intervention" for men, but as "conditions for medication maintenance" for women, it is not a difference in clinical pathways, but a question of the pricing power over female subjectivity.
In the medical field, which profoundly worships "rationality" and "objectivity," the masculine-centric narrative serves as the default biological benchmark. When doctors attribute women's symptoms to "anxiety" or "psychological factors," they are using cultural violence to erase biological facts. This complicity is subtle: by playing the role of the "cautious clinician," doctors subconsciously objectify the female body as a "low-priority" asset, thereby prioritizing high-value resources like surgery, stents, and transplants for men in the game of resource allocation.
The most ironic part is that this inequality remains highly consistent despite a total lack of supporting clinical guidelines. This means there is a set of meta-violence logic operating within the medical system—one that requires no written rules yet is executed by all: a man's life is a machine to be "repaired," while a woman's pain is an emotion to be "soothed." Pills are cheap pacifiers; the scalpel is the actual salvation.
Terms like "Women's Health Ambassador" or political rhetoric about "medical misogyny" are merely performative concessions in a PR version of progress, unless they dismantle the power structure of medical evaluation. As long as the medical benchmark remains masculine, women in hospitals will always be nothing more than a "deviation value" to be corrected.